Jupiter Life Line Hospitals Limited has announced an Earnings Conference Call for investors and analysts, scheduled for Monday, May 18, 2026, at 10:30 AM IST. The announcement was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was filed with the stock exchanges on May 11, 2026.

Conference Call Details

The call will focus on the company's operational and financial performance for Q4 & FY26. It will be represented by Dr. Ankit Thakker, Joint Managing Director and CEO, along with the Senior Management team. Investors and analysts are requested to pre-register for the call in advance.

The following table outlines the key details of the earnings conference call:

Access Information

Participants may join the call using the access numbers provided below:

The investor relations coordination for the call is being managed by Strategic Growth Advisors Pvt. Ltd., with contacts Mandar Chavan and Rahul Agarwal reachable at mandar.chavan@sgapl.net and rahul.agarwal@sgapl.net , or at 9699382195 and 9821438864 respectively.

Regulatory Filing

The intimation was submitted to both the National Stock Exchange of India Ltd. and BSE Limited on May 11, 2026. The filing was signed by Suma Upparatti, Company Secretary & Compliance Officer of Jupiter Life Line Hospitals Limited. The details of the conference call will also be made available on the company's official website at www.jupiterhospital.com .

Jupiter Life Line Hospitals Limited has informed the stock exchanges of a board meeting scheduled for Friday, May 15, 2026, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will take up several significant agenda items, including the review of audited financial results, a dividend declaration, and a share split proposal.

Key Agenda Items

The board meeting has been convened to consider a range of important corporate matters. The following table summarises the key agenda items scheduled for deliberation:

Interim Dividend and Record Date

In terms of Regulation 42 of the Listing Regulations, the company has set Friday, May 22, 2026 as the record date for determining shareholders entitled to receive the interim dividend for FY 2025-26, if declared by the Board of Directors. The dividend, if approved, will be paid on equity shares of the company.

Equity Share Split Proposal

The board will also consider a proposal for the sub-division/split of existing equity shares having a face value of Rs. 10 each, fully paid up. The manner of the split will be determined by the Board of Directors, subject to approval of the shareholders of the company and other requisite regulatory approvals.

Trading Window Closure

In accordance with the Company's Code of Conduct for Prevention, Regulation, Monitoring and Reporting of Insider Trading under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will remain closed for all Designated Persons and their Immediate Relatives until 48 hours from the conclusion of the board meeting.

The intimation has been filed with the National Stock Exchange of India Ltd. and BSE Limited, and will also be made available on the company's website at www.jupiterhospital.com , pursuant to Regulation 46(2) of the Listing Regulations. The notice was signed by Suma Upparatti, Company Secretary & Compliance Officer, on May 11, 2026.